FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167329130> ?p ?o ?g. }

• W2167329130 endingPage "128" @default.
• W2167329130 startingPage "120" @default.
• W2167329130 abstract "Practice NursingVol. 23, No. 3 ClinicalAtrial fibrillation 3: managementChristine CottrellChristine CottrellSearch for more papers by this authorChristine CottrellPublished Online:29 Sep 2013https://doi.org/10.12968/pnur.2012.23.3.120AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View articleAbstractChristine Cottrell outlines two approaches that underpin the management of AF: assessment and management of stroke risk and the management of rate and/or rhythmReferencesCorley SD, Epstein AE, DiMarco JP et al. (2004) Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation 109(12): 1509–13 Crossref, Google ScholarCamm AJ, Kirchhof P, Lip GY et al. (2010) Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19): 2369–29 Crossref, Google ScholarCamm AJ, Savelieva I, Lip GY et al. (2007) Rate control in the medical management of atrial fibrillation. Heart 93(1): 35–8 Crossref, Google ScholarConnolly SJ, Ezekowitz MD, Yusuf S et al. (2009) Dabigatran versus warfarin in patients with AF. N Engl J Med 361: 1139–51 Crossref, Google ScholarCosio FG, Aliot E, Botto GL et al. (2008) Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode. Europace 10: 21–7 Crossref, Google ScholarDharmarajan TS, Varma S, Akkaladevi S et al. (2006) To anticoagulate or not to anticoagulate? A common dilemma for the provider: physicians’ opinion poll based on a case study of an older long-term care facility resident with dementia and atrial fibrillation. J Am Med Dir Asso 7: 23–8 Crossref, Google ScholarDi Rocco JR, During A, Morelli PJ et al. (2011) Atrial fibrillation in healthy adolescents after highly caffeinated beverage consumption: two case reports. Med Case Reports 19(1): 18 Crossref, Google ScholarFogoros RN (2011) Dronedarone for Atrial Fibrillation Like amiodarone but without the toxicity? http://tiny.cc/1m464 (accessed 20 February 2012) Google ScholarFuster V, Rydén LE, Cannon DS et al. (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: executive summary. Circulation 114: 700–52 Crossref, Google ScholarGage BF, Waterman AD, Shannon W et al. (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285(22): 2864–70 Crossref, Google ScholarGladstone DJ, Bui E, Fang J et al. (2009) Potentially preventable strokes in high-risk patients with atrial fi brillation who are not adequately anticoagulated. Stroke 40: 235–40 Crossref, Google ScholarGranger CB, Alexander JH, McMurray JJV et al. (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365: 981–92 Crossref, Google ScholarHart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of International Medicine 146(12): 857–67 Crossref, Google ScholarHohnloser SH, Crijns HJGM, van Eickels M et al. (2009) Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 360: 668–78 Crossref, Google ScholarHylek EM, Go AS, Chang Y et al. (2003) Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349(11):1019–26 Crossref, Google ScholarIqbal MB, Taneja AK, Lip GY et al. (2005) Recent developments in atrial fibrillation. BMJ 330: 238–43 Crossref, Google ScholarKirchhof P, Auricchio A, Bax J et al. (2007) Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J 28: 2803–17 Crossref, Google ScholarKlatsky AL, Hasan AS, Armstrong MA et al. (2011) Coffee, caffeine, and risk of hospitalization for arrhythmias. Perm J 15(3): 19–25 Crossref, Google ScholarLinden B (2011) ESC Clinical Guideline on Management of Atrial Fibrillation. British Journal of Cardiac Nursing 6(5): 240–2 Link, Google ScholarLip G, Nieuwlaat R, Pisters R (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach. Chest 137(2): 263–72 Crossref, Google ScholarMant J, Hobbs FD, Fletcher K et al. (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370(9586): 493–503 Crossref, Google ScholarMartí-Fàbregas J, Mateo J (2009) Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke. Cerebrovascular Disease 27(Suppl 1): 111–19 Crossref, Google ScholarMedicines and Healthcare Products Regulatory Agency (2011) Dronedarone: risk of cardiac failure and risk of hepatotoxicity. Drug Safety Update 4(7): A1 Google ScholarMedtronic Inc (2010) Stop AF trial: arctic front cardiac cryoablation catheter system reduces AF symptoms by 80%. http://tiny.cc/5yhyu (accessed 13 february 2012) Google ScholarNHS Stroke Improvement Programme (2009) Atrial fibrillation: detection and optimal therapy in primary care. www.evidence.nhs.uk/qualityandproductivity (accessed 13 February 2012) Google ScholarNational Institute for Health and Clinical Excellence (2010)Dronedarone for the Treatment of Non-Permanent Atrial Fibrillation. Technology appraisal 197. http://tiny.cc/f1nkt (accessed 13 February 2012) Google ScholarNational Institute for Health and Clinical Excellence (2011) The Quality and Outcomes Framework. http://tiny.cc/nwkwx (accessed 22 February 2012) Google ScholarNational Institute for Health and Clinical Excellence (2006) Atrial fibrillation: The Management of Atrial Fibrillation. Clinical guideline 36.http://tiny.cc/ktl68 (accessed 13 February 2012) Google ScholarOgbru O (2012) Beta blockers. http://tiny.cc/g4s8q (accessed 20 February 2012) Google ScholarPatel MR, Mahaffey KW, Garg J et al. (2011) Rivaroxaban versus warfarin in non-valvular atrial fibrillation. N Engl J Med 365: 883–91 Crossref, Google ScholarPisters R, Lane DA, Nieuwlaat R et al. (2010) A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: the euro heart survey. Chest 138(5): 1093–100 Crossref, Google ScholarPodrid PJ, Anderson JL (1996) Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias: The propafenone multi-center study group. Am J Cardiol 78(4): 430–4 Crossref, Google ScholarRoy D, Talajic M, Nattel S et al. (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358: 2667–77 Crossref, Google ScholarSamokhvalov AV, Irving HM, Rehm J (2010) Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 17(6): 706–12 Crossref, Google ScholarSavelieva I, Camm AJ (2007) Is there any hope for angiotensin-converting enqyme inhibitors in atrial fibrillation? Am Heart J 154: 403–6 Crossref, Google ScholarShen J, Johnson VM, Sullivan LM (2011) Dietary factors and incident atrial fibrillation: the Framingham Heart Study. Am J Clin Nutr 93(2): 261–6 Crossref, Google ScholarWatson T, Shantsila E, Lip GY (2009) Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet 373(9658): 155–166 Crossref, Google ScholarWeitz Jl (2010) New oral anticoagulants in development. Thromb Haemost 103(1): 62–70 Crossref, Google Scholar FiguresReferencesRelatedDetails 1 March 2012Volume 23Issue 3ISSN (print): 0964-9271ISSN (online): 2052-2940 Metrics Downloaded 16 times History Received 12 February 2012 Accepted 13 February 2012 Published online 29 September 2013 Published in print 1 March 2012 Information© MA Healthcare LimitedKeywordsThromboembolicCHADS2CHA2DS2-VAScHAS-BLEDraterhythmPDF download" @default.
• W2167329130 created "2016-06-24" @default.
• W2167329130 creator A5040757796 @default.
• W2167329130 date "2012-03-01" @default.
• W2167329130 modified "2023-10-14" @default.
• W2167329130 title "Atrial fibrillation 3: management" @default.
• W2167329130 cites W107772953 @default.
• W2167329130 cites W1207268963 @default.
• W2167329130 cites W1982036945 @default.
• W2167329130 cites W1999468381 @default.
• W2167329130 cites W2062786076 @default.
• W2167329130 cites W2078635445 @default.
• W2167329130 cites W2089534375 @default.
• W2167329130 cites W2097854437 @default.
• W2167329130 cites W2099340353 @default.
• W2167329130 cites W2100052214 @default.
• W2167329130 cites W2100149246 @default.
• W2167329130 cites W2100365169 @default.
• W2167329130 cites W2104343448 @default.
• W2167329130 cites W2112547797 @default.
• W2167329130 cites W2119808478 @default.
• W2167329130 cites W2127985968 @default.
• W2167329130 cites W2131260805 @default.
• W2167329130 cites W2136489990 @default.
• W2167329130 cites W2139658251 @default.
• W2167329130 cites W2145263956 @default.
• W2167329130 cites W2147797899 @default.
• W2167329130 cites W2154752334 @default.
• W2167329130 cites W2159730165 @default.
• W2167329130 cites W2160464880 @default.
• W2167329130 cites W2161696103 @default.
• W2167329130 cites W2162508946 @default.
• W2167329130 cites W2162586165 @default.
• W2167329130 cites W2164861810 @default.
• W2167329130 cites W2517864976 @default.
• W2167329130 cites W4251819669 @default.
• W2167329130 doi "https://doi.org/10.12968/pnur.2012.23.3.120" @default.
• W2167329130 hasPublicationYear "2012" @default.
• W2167329130 type Work @default.
• W2167329130 sameAs 2167329130 @default.
• W2167329130 citedByCount "0" @default.
• W2167329130 crossrefType "journal-article" @default.
• W2167329130 hasAuthorship W2167329130A5040757796 @default.
• W2167329130 hasConcept C126322002 @default.
• W2167329130 hasConcept C164705383 @default.
• W2167329130 hasConcept C177713679 @default.
• W2167329130 hasConcept C2779161974 @default.
• W2167329130 hasConcept C2780971015 @default.
• W2167329130 hasConcept C71924100 @default.
• W2167329130 hasConceptScore W2167329130C126322002 @default.
• W2167329130 hasConceptScore W2167329130C164705383 @default.
• W2167329130 hasConceptScore W2167329130C177713679 @default.
• W2167329130 hasConceptScore W2167329130C2779161974 @default.
• W2167329130 hasConceptScore W2167329130C2780971015 @default.
• W2167329130 hasConceptScore W2167329130C71924100 @default.
• W2167329130 hasIssue "3" @default.
• W2167329130 hasLocation W21673291301 @default.
• W2167329130 hasOpenAccess W2167329130 @default.
• W2167329130 hasPrimaryLocation W21673291301 @default.
• W2167329130 hasRelatedWork W1967841144 @default.
• W2167329130 hasRelatedWork W2018480046 @default.
• W2167329130 hasRelatedWork W2070311648 @default.
• W2167329130 hasRelatedWork W2319489406 @default.
• W2167329130 hasRelatedWork W2321888776 @default.
• W2167329130 hasRelatedWork W2763816051 @default.
• W2167329130 hasRelatedWork W3031548039 @default.
• W2167329130 hasRelatedWork W3108259679 @default.
• W2167329130 hasRelatedWork W3162416582 @default.
• W2167329130 hasRelatedWork W3215934207 @default.
• W2167329130 hasVolume "23" @default.
• W2167329130 isParatext "false" @default.
• W2167329130 isRetracted "false" @default.
• W2167329130 magId "2167329130" @default.
• W2167329130 workType "article" @default.